SCHEMBL2413686

SCHEMBL2413686

Nc1ccc(N2CCCCC2)nc1N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.54
SMPD3 Q9NY59 2/20 0.50
CNR2 P34972 2/20 0.48
MAPT P10636 5/20 0.45
ALDH1A1 P00352 4/20 0.45
MAPK1 P28482 3/20 0.45
TDP1 Q9NUW8 2/20 0.45
POLB P06746 1/20 0.45
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CYP1A2 P05177 2/20 0.44
PARP1 P09874 2/20 0.44
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.43
MEN1 O00255 2/20 0.43
GAA P10253 2/20 0.43
KMT2A Q03164 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
S100B P04271 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2412557 0.98 MAP4K4 (0.51) MAP4K4SMPD3CNR2MAPTALDH1A1
Hydrochloric Acid SCHEMBL6337864 0.96 MAP4K4 (0.50) MAP4K4SMPD3CNR2MAPTALDH1A1
SCHEMBL2417923 0.81 HTR3A (0.59) MAP4K4ALDH1A1CYP1A2HRH4
SCHEMBL29546459 0.81 HRH3 (0.57) ALDH1A1MAPK1TDP1CYP1A2HTT
SCHEMBL29739643 0.81 SMPD3 (0.47) MAP4K4SMPD3CNR2MAPTALDH1A1
SCHEMBL25187814 0.81 CNR2 (0.52) MAP4K4SMPD3CNR2MAPTALDH1A1
SCHEMBL31570599 0.81 SMPD3 (0.53) SMPD3MAPTALDH1A1POLBCRHBP
SCHEMBL939415 0.81 SMPD3 (0.53) SMPD3MAPTALDH1A1POLBCRHBP
SCHEMBL4636410 0.81 SMPD3 (0.47) MAP4K4SMPD3CNR2MAPTALDH1A1
SCHEMBL29757651 0.81 HTR3A (0.59) MAP4K4ALDH1A1CYP1A2HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1312606-B1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres OREAL (FR) 2011-09-21 EP claimed
CN-1250192-C 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2006-04-12 CN claimed
CN-1425365-A 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2003-06-25 CN claimed
EP-1312606-A1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres L'OREAL (FR) 2003-05-21 EP claimed
US-20180111927-A1 HETEROCYCLIC-IMIDAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI HUILUN LIFE SCIENCE & TECHNOLOGY CO., LTD (CN) 2018-04-26 US disclosed
EP-1312606-B1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres OREAL (FR) 2011-09-21 EP disclosed
CN-1250192-C 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2006-04-12 CN disclosed
CN-1425365-A 2,5-diaminopyridine oxidation color display alkali for dyeing keratin fibre OREAL (FR) 2003-06-25 CN disclosed
EP-1312606-A1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres L'OREAL (FR) 2003-05-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180111927-A1 HETEROCYCLIC-IMIDAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF PARP1, PARP8, PARP11 MAP4K4 2102/4885SMPD3 3637/4885CNR2 1714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.